DETEKSI DINI DISLIPIDEMIA PADA TENAGA PENDIDIK SEKOLAH DASAR

Main Article Content

Enny Irawaty
Muhammad Ajib Ardin
Fernando Yosafat

Abstract

Dyslipidemia is a lipid imbalance such as cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides, and high-density lipoprotein (HDL). This condition can be caused by diet, tobacco exposure, or genetics and can lead to cardiovascular disease with severe complications. High cholesterol levels often have no symptoms, so most people do not realize that their cholesterol is too high, and they rarely carry out early detection. The survey showed that our clients, primary school teachers, rarely do cholesterol tests. They often consume foods that contain cholesterol and are physically inactive due to their busy daily activities. Based on client problems, the community service team of FK UNTAR intends to check blood cholesterol levels. The aim of this PKM activity is to increase awareness of the importance of blood cholesterol level checking and increase insight regarding how to maintain cholesterol levels in the body in a normal condition. A total of 23 participants took part in this activity. The results showed that 26.1% of participants had high total cholesterol levels, 34.8% of participants had LDL cholesterol levels close to optimal and borderline, 8.7% of participants had low HDL cholesterol levels, 82.6% of participants had normal triglyceride levels, and 21.7% of participants experienced dyslipidemia. The results of this activity showed that participants with dyslipidemia were quite high. It is hoped that this activity can increase participants' awareness so that they can monitor or carry out regular cholesterol checks in an effort to prevent the emergence of metabolic disease disorders in the future.

Article Details

Section
Articles

References

Center for Disease Control and Prevention. Cholesterol Myths and Facts [Internet]. 2022. Available from: https://www.cdc.gov/cholesterol/myths_facts.

Defesche JC, Gidding SS, Harada-Shiba M, Hegele RA, Santos RD, Wierzbicki AS. Familial hypercholesterolaemia. Nat Rev Dis Primers. 2017 7;3:17093. doi: 10.1038/nrdp.2017.93. https://pubmed.ncbi.nlm.nih.gov/29219151/

Eckel, R.H., & Cornier, M.A., 2014. Update on NCEP ATP-III Emerging Cardiometabolic Risk Factors. BMC Med, 12,115. doi: https://doi.org/10.1186/1741-7015-12-115

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA. Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation [Internet]. 2019;139(25):e1082–143. Available from: https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000000625

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., Wilson, D. P., & Brown, W. V. (2015). National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. Journal of clinical lipidology, 9(2), 129–169. https://doi.org/10.1016/j.jacl.2015.02.003

Kementerian Kesehatan Republik Indonesia (Kemenkes RI). 2019. Laporan Nasional Riskesdas 2018. Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan, Jakarta. Retrieved from: https://repository.badankebijakan.kemkes.go.id/id/eprint/3514

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, et al . Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. https://pubmed.ncbi.nlm.nih.gov/26673558/

Pappan N, Rehman A. Dyslipidemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560891/

Soebardi, S., Purnamasari, D., Oermardi, M., Soewondo, P., Waspaji, S., & Soegondo, S. 2009. Dyslipidemia in Newly Diagnosis Diabetes Melitus. The Jakarta Primary Non-Communicable Disease Risk Factors Surveillance 2006. Acta Medica Indonesiana, 41(4):186-190. PMID: 20124614. Retrived from: https://pubmed.ncbi.nlm.nih.gov/20124614/

Soegondo, S. 2005. Atherogenic Dyslipidemia and The Metabolic Syndrome. Acta Mediva Indonesiana, 37(3),177-183. PMID: 16110179. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/16110179/

Tsao CW, Aday AW, Almarzooq ZI, Beaton AZ, Bittencourt MS, Boehme AK. 2022. Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation. ;145(8):e153–e639

World Health Organization (WHO). 2022. Noncommunicable diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

World Health Organization (WHO). 2023. Raised Cholesterol. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3236